This inventor holds 1 USPTO granted patent. Top assignee: Enbiar Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Byeong Nam Im: Innovator in Polymer Technology
Introduction
Byeong Nam Im is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of polymer technology, particularly in the area of medical applications. His innovative work focuses on developing solutions to combat antibiotic resistance and improve diagnostic methods.
Latest Patents
One of Byeong Nam Im's key patents is titled "Polymer composite for helicobacter pylori recognition and composition for photodynamic therapy comprising same." This invention relates to a polymer complex designed for recognizing Helicobacter pylori, a bacterium associated with various gastrointestinal diseases. The polymer-photosensitizer complex he developed is water-soluble and features sialyllactose, which selectively binds to the surface of the bacterium. This complex exhibits excellent selectivity and binding power, generating singlet oxygen when irradiated with laser light. This process effectively induces the inactivation of the bacterium, providing a promising approach for both detection in the gastrointestinal tract and photodynamic therapy to address antibiotic resistance issues. Byeong Nam Im holds 1 patent for this groundbreaking invention.
Career Highlights
Byeong Nam Im is currently associated with Enbiar Inc., where he continues to advance his research and development efforts. His work at the company emphasizes the importance of innovative solutions in the medical field, particularly in addressing pressing health challenges.
Collaborations
Byeong Nam Im collaborates with Kun Na, contributing to the advancement of their shared research interests. Their partnership enhances the potential for innovative breakthroughs in polymer technology and medical applications.
Conclusion
Byeong Nam Im is a distinguished inventor whose work in polymer technology is paving the way for new medical solutions. His innovative patent addressing Helicobacter pylori recognition and photodynamic therapy exemplifies his commitment to improving healthcare outcomes.